Transient inactivation of the neonatal ventral hippocampus impairs attentional set-shifting behavior: Reversal with an α7 nicotinic agonist

Neuropsychopharmacology

Volumn 37, Issue 11, 2012, Pages 2476-2486

  Brooks, Julie M ^a   Pershing, Michelle L ^a   Thomsen, Morten S ^b   Mikkelsen, Jens D ^b   Sarter, Martin ^c   Bruno, John P ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

alpha7 nicotinic acetylcholine receptors; attentional set shifting; prefrontal cortex; schizophrenia; tetrodotoxin; ventral hippocampus

Indexed keywords

1,4 DIAZABICYCLO[3.2.2]NONANE 4 CARBOXYLIC ACID 4 BROMOPHENYL ESTER; TETRODOTOXIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTIONAL SET SHIFTING BEHAVIOR; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NEWBORN; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; VENTRAL HIPPOCAMPUS;

AGE FACTORS; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; ANIMALS; ANIMALS, NEWBORN; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BICYCLO COMPOUNDS, HETEROCYCLIC; DISCRIMINATION (PSYCHOLOGY); DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; NICOTINIC AGONISTS; ODORS; RATS; RATS, WISTAR; SET (PSYCHOLOGY); TETRODOTOXIN; TOUCH;

EID: 84866426603     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.106     Document Type: Article

References (85)

1. Alexander KS, Brooks JM, Sarter M, Bruno JP (2009). Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment. Neuropsychopharmacology 34: 2710-2720.
2. Barak S, Arad M, De Levie A, Black MD, Griebel G, Weiner I (2009). Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia. Neuropsychopharmacology 34: 1753-1763.
3. Birrell JM, Brown VJ (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20: 4320-4324. (Pubitemid 30365702)
4. Biton B, Bergis OE, Galli F, Nedelec A, Lochead AW, Jegham S et al (2007). SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (I) binding and functional profile. Neuropsychopharmacology 32: 1-16. (Pubitemid 44967780)
5. Bortz DM, Brooks JM, Sarter M, Bruno JP (2011). Program No. 368.02. 2011 Neuroscience Meeting Planner, Society for Neuroscience: Washington, DC. Brady AM (2009). Neonatal ventral hippocampal lesions disrupt set-shifting in adult rats. Behav Brain Res 205: 294-298.
6. Brady AM, Saul RD, Wiest MK (2010). Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia. Neuropharmacology 59: 605-611.
7. Brooks JM, Sarter M, Bruno JP (2007). D2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex. Neuropharmacology 53: 455-463. (Pubitemid 47212252)
8. Brooks JM, Sarter M, Bruno JP (2011). Transient inactivation of the neonatal ventral hippocampus permantly disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia. Neuropsychopharmacology 36: 2477-2487.
9. Buchanan RW, Conley RR, Dickinson D, Ball MP, Feldman S, Gold JM.et al (2008). Galantamine for the treatment of cognitive impairments in people with schizophrenia. Am J Psychiatry 165: 82-89. (Pubitemid 351704556)
10. Chambers RA, Krystal JH, Self DW (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiaty 50: 71-83.
11. Chambers RA, Moore J, McEvoy JP, Levin ED (1996). Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 15: 587-594. (Pubitemid 26400763)
12. Csernansky JG, Wrona CT, Bardgett ME (1993). Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology 110: 145-151. (Pubitemid 23029441)
13. Czerniawski J, Ree F, Chia C, Otto T (2011). Dorsal vs ventral hippocampal contributions to trace and contextual conditioning: differential effects of regionally selective nmda receptor antagonism on acquisition and expression. Hippocampus; e-pub ahead of print 19 December 2011.
14. Czerniawski J, Yoon T, Otto T (2009). Dissociating space and trace in dorsal and ventral hippocampus. Hippocampus 19: 20-32.
15. Dalley JW, Cardinal RN, Robbins TW (2004). Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev 28: 771-784. (Pubitemid 39535871)
16. Dolorfo CL, Amaral DG (1998). Entorhinal cortex of the rat: organization of intrinsic connections. J Comp Neurol 398: 49-82. (Pubitemid 28373876)
17. Drakew A, Frotscher M, Heimrich B (1999). Blockade of neuronal activity alters spine maturation of dentate granule cells but not their dendritic arborization. Neuroscience 94: 767-774. (Pubitemid 29474964)
18. Flores G, Alquicer G, Silva-Gomez AB, Zaldivar G, Stewart J, Quirion R et al (2005). Alerations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133: 463-470. (Pubitemid 40726213)
19. Floresco SB, Ghods-Sharifi S, Vexelman C, Magyar O (2006). Dissociable roles for the nucleus accumbens core and shell in regulating set shifting. J Neurosci 26: 2449-2457. (Pubitemid 44699005)
20. Floresco SB, Zhang Y, Enomoto T (2009). Neural circuits subserving behavioral flexibility and their relevance to schizophrenia. Behav Brain Res 204: 396-409.
21. Francois J, Ferrandon A, Koning E, Angst M-J, Sander G, Nehling A (2009). Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats. Int J Neuropsychopharmacol 12: 1097-1110.
22. French SJ, Totterdell S (2003). Individual nucleus accumbensprojection neurons receive both basolateral amysdala and ventral subicular afferents in rats. Neuroscience 119: 19-31. (Pubitemid 36577408)
23. Ghods-Sharifi S, Haluk DM, Floresco SB (2008). Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning. Neurobiol Learn Mem 89: 567-573. (Pubitemid 351484252)
24. Goldman MB, Mitchell CP (2004). What is the functional significance of hippocampal pathology in schizophrenia? Schizophr Bull 30: 367-392. (Pubitemid 38828543)
25. Goto Y, O'Donnell P (2002). Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. J Neurosci 22: 9070-9077. (Pubitemid 35379077)
26. Goto Y, Grace AA (2005). Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci 8: 805-812. (Pubitemid 43085848)
27. Gray JA (1998). Integrating Schizophrenia. Schizophr Bull 24: 249-266. (Pubitemid 28404984)
28. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B (1999). Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 20: 525-532. (Pubitemid 29189257)
29. Green MF, Kern RS, Heaton RK (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72: 41-51. (Pubitemid 39452904)
30. Groenewegen H, Vermeulenvanderzee E, Dortschot A, Witter M (1987). Organization of the projections from the subiculum to the ventral striatum in the rat-A study using anterograde transport of phaseolus-vulgaris leukoagglutinin. Neuroscience 23: 103-120. (Pubitemid 17159558)
31. Hansen HH, Timmermann DB, Peters D, Walters C, Damai MI, Mikkelsen JD (2007). Alpha-7 nicotinic acetylcholine receptor agonists selectively activate limbic regions of the rat forebrain: an effect similar to antipsychotics. J Neurosci Res 85: 1810-1818. (Pubitemid 46849628)
32. Harrison PJ (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174: 151-162. (Pubitemid 38925100)
33. Hasselmo ME, Sarter M (2011). Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36: 52-73.
34. Henny P, Jones BE (2008). Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci 27: 654-670. (Pubitemid 351239287)
35. Henseler I, Falkai P, Gruber O (2010). Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatric Res 44: 364-372.
36. Jay TM, Glowinski J, Thierry AM (1989). Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res 505: 337-340. (Pubitemid 20013176)
37. Keefe RS (2007). Cognitive deficits in patients with schizophrenia: effects and treatments. J Clin Psychiatry 68(Suppl 14): 8-13.
38. Kehagia AA, Murray GK, Robbins TW (2010). Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol 20: 199-204.
39. Kerns JG, Nuechterlein KH, Braver TS, Barch DM (2008). Executive functioning component mechanisms and schizophrenia. Biol Psychiatry 64: 26-33. (Pubitemid 351783247)
40. Laplante F, Srivastava LK, Quirion R (2004). Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions. J Neuroch 89: 314-323. (Pubitemid 38495980)
41. Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TRE et al (2009). Discrimination learning, reversal, and setshifting in first-episode schizophrenia: stability over six years and specific associations with medication type and disorganization syndrome. Biol Psychiatry 66: 586-593.
42. Le Pen G, Moreau JL (2002). Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacolog 27: 1-11. (Pubitemid 34626738)
43. Lewis DA, Gonzalez-Burgos G (2008). Neuroplasticity of neocortical circuits in schizophrenia. Neuropsychopharmacology 33: 141-165. (Pubitemid 350191315)
44. Lindenmayer JP, Khan A (2011). Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia. Schizophr Res 125: 267-277.
45. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B (2002a). Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 27: 47-54. (Pubitemid 34626742)
46. Lipska BK, Halim ND, Segal PN, Weinberger DR (2002b). Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22: 2835-2842. (Pubitemid 37465832)
47. Lipska BK, Lerman DN, Khaing ZZ, Weinberger DR (2003). The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain. Eur J Neurosci 18: 3097-3104. (Pubitemid 38021551)
48. Lipska BK, Weinberger DR (2002). A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 4: 469-475.
49. Lisman JE, Pi HJ, Zhang YC, Otmakhova NA (2010). A thalamohippocampal- ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia. Bio Psychiatry 68: 17-24.
50. Marquis JP, Goulet S, Dore FY (2008). Neonatal ventral hippocampus lesions disrupt extra-dimensional shift and alter dendritic spine density in the medial prefrontal cortex of juvenile rats. Neurobiol Learn Mem 90: 339-346.
51. Martin LF, Freedman R (2007). Schizophrenia and the alpha7 nicotinic acetylcholine receptor. Int Rev Neurobiol 78: 225-246.
52. Meyer F, Peterschmitt Y, Louilot A (2009). Postnatal functional inactivation of the entorhinal cortex or ventral subiculum has different consequences for latent inhibition-related striatal dopaminergic responses in adult rats. Eur J Neurosci 29: 2035-2048.
53. Miller EK, Cohen JD (2001). An integrative theory of prefrontal cortex function. Annu Rev Neuroscience 24: 167-202. (Pubitemid 32695227)
54. Miller EJ, Saint Marie LR, Breier MR, Swerdlow NR (2010). Pathways from the ventral hippocampus and caudal amygdala to forebrain regions that regulate sensorimotor gating in the rat. Neuroscience 165: 601-611.
55. Nuechterlein KH, Luck SJ, Lustig C, Sarter M (2009). CNTRICS final task selection: control of attention. Schizophr Bull 35: 182-196.
56. O'Donnell P, Grace AA (1995). Synaptic interactions among excitatory afferent to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. J Neurosci 15: 3622-3693.
57. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK (2002). Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12: 975-982.
58. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D et al (2006). Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63: 630-638. (Pubitemid 43848294)
59. Pantelis C, Barber FZ, Barnes TR, Nelson HE, Owen AM, Robbins TW (1999). Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37: 251-270. (Pubitemid 29298095)
60. Pershing ML, Bortz DM, Alexander KS, Brooks JM, Mikkelsen JD, Thomsen MS et al (2011). Program No. 163.17. 2011 Neuroscience Meeting Planner, Society for Neuroscience: Washington, DC.
61. Peterschmitt Y, Meyer F, Louilot A (2007). Neonatal functional blockade of the entorhinal cortex results in disruption of accumbal dopaminergic responses observed in latent inhibition paradigm in adult rats. Eur J Neurosci 25: 2504-2513. (Pubitemid 46625932)
62. Peterschmitt Y, Meyer F, Louilot A (2008). Differential influence of the ventral subiculum on dopaminergic responses observed in core and dorsomedial shell subregions of the nucleus accumbens in latent inhibition. Neuroscience 154: 898-910.
63. Pichat P, Bergis OE, Terranova JP, Urani A, Duarte C, Santucci V et al (2007). SSR180711: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32: 17-34.
64. Robbins TW (2007). Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci 362: 917-932. (Pubitemid 47056819)
65. Rygula R, Walker SC, Clarke HF, Robbins TW, Roberts AC (2010). Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 27: 14552-14559.
66. Sarter M, Hasselmo ME, Bruno JP, Givens B (2005). Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res Brain Res Rev 48: 98-111. (Pubitemid 40215784)
67. Sarter M, Markowitsch HJ (1984). Collateral innervation of the medial and lateral prefrontal cortex by amygdaloid, thalamic and brain-stem neurons. J Comp Neurol 224: 445-460. (Pubitemid 14137355)
68. Schmidt-Hansen M, Killcross A, Honey RC (2009). Latent inhibition, learned irrelevance, and schizotypy: assessing their relationship. Cogn Neuropsychiatry 14: 11-29.
69. Schubert MH, Young KA, Hicks PB (2006). Galantamine improves cognition in schizophrenia patients stabilized on risperidone. Biol Psychiatry 60: 530-533. (Pubitemid 44402376)
70. Stefani MR, Moghaddam B (2005). Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci 119: 420-428. (Pubitemid 40547947)
71. St Peters M, Demeter E, Lustig C, Bruno JP, Sarter M (2011). Enhanced control of attention by stimulating mesolimbiccorticopetal cholinergic circuitry. J Neurosci 31: 9760-9771.
72. Sutor B, Luhmann HJ (1995). Development of excitatory and inhibitory postsynaptic potentials in the rat neocortex. Perspect Dev Neurobiol 2: 409-419.
73. Tait DS, Marston HM, Shahid M, Brown VJ (2009). Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacology 202: 295-306.
74. Tamminga CA, Stan AD, Wagner AD (2010). The hippocampal formation in schizophrenia. Am J Psychiatry 167: 1178-1193.
75. Thomsen MS, Christensen DZ, Hansen HH, Redrobe JP, Mikkelsen JD (2009). Alpha(7) nicotinic acetylcholine receptor activation prevents behavioral and molecular changes induced by repeated phencyclidine treatment. Neuropharmacology 56: 1001-1009.
76. Thomsen MS, Hay-Schmidt A, Hansen HH, Mikkelsen JD (2010). Distinct neural pathways mediate alpha7 nicotinic acetylcholine receptor-dependent activation of the forebrain. Cereb Cortex 20: 2092-2102.
77. Tierney PL, Degentetais E, Thierry AM, Glowinski J, Gioanni Y (2004). Influence of the hippocampus on interneurons of the rat prefrontal cortex. Eur J Neurosci 20: 514-524. (Pubitemid 38969636)
78. Tregellas JR, Tanabe J, Rojas DC, Shatti S, Olincy A, Johnson L et al (2011). Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry 69: 7-11.
79. Tseng KY, Chambers RA, Lipska BK (2009). The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behav Brain Res 204: 295-305.
80. Vasey MW, Thayer JF (1987). The continuing problem of false positives in repeated measures ANOVA in psychophysiology-a multivariate solution. Psychophysiology 24: 479-486. (Pubitemid 17114214)
81. Wolf RC, Vasic N, Sambataro F, Hose A, Frasch K, Schmid M et al (2009). Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippocampal connectivity in patients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 33: 1464-1473.
82. Yang CR, Seamans JK, Gorelova N (1999). Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex. Neuropsychopharmacology 21: 161-194. (Pubitemid 29304579)
83. Young AM, Kumari V, Mehrotra R, Hemsley DR, Andrew C, Sharma T et al (2005). Dirsuption of learned irrelevance in acute schizophrenia in a novel continuous within-subject paradigm suitable for fMRI. Behav Brain Res 156: 277-288. (Pubitemid 39576068)
84. Zaborszky L, Cullinan WE (1992). Projections from the nucleus accumbens to cholinergic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in rat. Brain Res 570: 92-101.
85. Zmarowski AL, Sarter M, Bruno JP (2005). NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. Eur J Neurosci 22: 1731-1740. (Pubitemid 41482961)